Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

A patient with sickle cell trait and low vitamin D might have lupus, a rare combination that needs more attention.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.